Technical Analysis for QTRX - Quanterix Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
23.74 | -4.35% | -1.08 |
QTRX closed down 4.35 percent on Thursday, February 27, 2020, on 1.21 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical QTRX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Spinning Top | Other | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 200 DMA | Bearish | -4.35% | |
| Fell Below 50 DMA | Bearish | -4.35% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/09/2020
- Sector: Healthcare
- Industry: Biotechnology
Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.
Biotechnology Healthcare Life Sciences Biology Disease Inflammation Infectious Disease Biomarkers
Biotechnology Healthcare Life Sciences Biology Disease Inflammation Infectious Disease Biomarkers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 36.15 |
| 52 Week Low | 19.08 |
| Average Volume | 120,889 |
| 200-Day Moving Average | 25.93 |
| 50-Day Moving Average | 25.30 |
| 20-Day Moving Average | 27.28 |
| 10-Day Moving Average | 27.03 |
| Average True Range | 1.25 |
| ADX | 29.03 |
| +DI | 13.08 |
| -DI | 30.59 |
| Chandelier Exit (Long, 3 ATRs ) | 25.25 |
| Chandelier Exit (Short, 3 ATRs ) | 26.76 |
| Upper Bollinger Band | 29.72 |
| Lower Bollinger Band | 24.84 |
| Percent B (%b) | -0.22 |
| BandWidth | 17.90 |
| MACD Line | 0.03 |
| MACD Signal Line | 0.61 |
| MACD Histogram | -0.5795 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 26.58 | ||||
| Resistance 3 (R3) | 26.65 | 25.77 | 26.10 | ||
| Resistance 2 (R2) | 25.77 | 25.05 | 25.74 | 25.94 | |
| Resistance 1 (R1) | 24.76 | 24.61 | 24.32 | 24.69 | 25.79 |
| Pivot Point | 23.88 | 23.88 | 23.67 | 23.85 | 23.88 |
| Support 1 (S1) | 22.87 | 23.16 | 22.43 | 22.80 | 21.69 |
| Support 2 (S2) | 21.99 | 22.72 | 21.96 | 21.54 | |
| Support 3 (S3) | 20.98 | 21.99 | 21.38 | ||
| Support 4 (S4) | 20.91 |
